Spots Global Cancer Trial Database for unresectable renal cell carcinoma

Every month we try and update this database with for unresectable renal cell carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cancer	NCT05122546	Advanced Clear ... Advanced Papill... Advanced Renal ... Advanced Sarcom... Metastatic Clea... Metastatic Papi... Metastatic Rena... Metastatic Sarc... Stage III Renal... Stage IV Renal ... Unresectable Cl... Unresectable Re...	Cabozantinib S-... Clostridium but... Nivolumab	18 Years -	City of Hope Medical Center
Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies	NCT02419495	Advanced Malign... Clinical Stage ... Clinical Stage ... Fallopian Tube ... Metastatic Lung... Metastatic Mali... Metastatic Mela... Metastatic Rena... Ovarian Carcino... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Primary Periton... Stage III Lung ... Stage III Renal... Stage IIIA Lung... Stage IIIB Lung... Stage IIIC Lung... Stage IV Lung C... Stage IV Renal ... Stage IVA Lung ... Stage IVB Lung ... Triple-Negative... Unresectable Lu... Unresectable Me... Unresectable Re...	Capecitabine Carboplatin Cyclophosphamid... Doxorubicin Eribulin Fluorouracil Ipilimumab Irinotecan Hydr... Leucovorin Calc... Nivolumab Olaparib Oxaliplatin Paclitaxel Pembrolizumab Pemetrexed Selinexor Topotecan	18 Years -	M.D. Anderson Cancer Center
Talazoparib and Axitinib for People With Previously Treated Advanced Kidney Cancer	NCT04337970	Kidney Cancer Renal Cell Carc... Unresectable Re... Metastatic Rena...	Talazoparib Axitinib	18 Years -	Memorial Sloan Kettering Cancer Center
CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cancer	NCT05122546	Advanced Clear ... Advanced Papill... Advanced Renal ... Advanced Sarcom... Metastatic Clea... Metastatic Papi... Metastatic Rena... Metastatic Sarc... Stage III Renal... Stage IV Renal ... Unresectable Cl... Unresectable Re...	Cabozantinib S-... Clostridium but... Nivolumab	18 Years -	City of Hope Medical Center
Talazoparib and Axitinib for People With Previously Treated Advanced Kidney Cancer	NCT04337970	Kidney Cancer Renal Cell Carc... Unresectable Re... Metastatic Rena...	Talazoparib Axitinib	18 Years -	Memorial Sloan Kettering Cancer Center
Pamiparib and Temozolomide for the Treatment of Hereditary Leiomyomatosis and Renal Cell Cancer	NCT04603365	Clear Cell Papi... Collecting Duct... Hereditary Leio... Hereditary Papi... Metastatic Rena... Metastatic Uncl... Papillary Renal... Stage III Renal... Stage IV Renal ... Tubulocystic Re... Unresectable Re...	Pamiparib Temozolomide	18 Years -	Jonsson Comprehensive Cancer Center
CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cancer	NCT05122546	Advanced Clear ... Advanced Papill... Advanced Renal ... Advanced Sarcom... Metastatic Clea... Metastatic Papi... Metastatic Rena... Metastatic Sarc... Stage III Renal... Stage IV Renal ... Unresectable Cl... Unresectable Re...	Cabozantinib S-... Clostridium but... Nivolumab	18 Years -	City of Hope Medical Center
CBM588, Nivolumab, and Ipilimumab in Treating Patients With Stage IV or Advanced Kidney Cancer	NCT03829111	Advanced Renal ... Clear Cell Rena... Metastatic Rena... Stage III Renal... Stage IV Renal ... Unresectable Re...	Clostridium but... Ipilimumab Nivolumab	18 Years -	City of Hope Medical Center
Testing Cabozantinib, Crizotinib, Savolitinib and Sunitinib in Kidney Cancer Which Has Progressed	NCT02761057	Locally Advance... Metastatic Papi... Stage III Renal... Stage IV Renal ... Type 1 Papillar... Type 2 Papillar... Unresectable Re...	Biospecimen Col... Bone Scan Cabozantinib S-... Computed Tomogr... Crizotinib Savolitinib Sunitinib Malat...	18 Years -	National Cancer Institute (NCI)
Pazopanib Hydrochloride With or Without Ascorbic Acid in Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed by Surgery	NCT03334409	Clear Cell Rena... Metastatic Clea... Stage III Renal... Stage IV Renal ... Unresectable Re...	Ascorbic Acid Pazopanib Hydro...	18 Years -	Academic and Community Cancer Research United
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Study	NCT05327686	Metastatic Rena... Stage III Renal... Stage IV Renal ... Unresectable Re...	Avelumab Axitinib Cabozantinib Ipilimumab Lenvatinib Nivolumab Pembrolizumab Stereotactic Ab...	18 Years -	NRG Oncology
CBM588, Nivolumab, and Ipilimumab in Treating Patients With Stage IV or Advanced Kidney Cancer	NCT03829111	Advanced Renal ... Clear Cell Rena... Metastatic Rena... Stage III Renal... Stage IV Renal ... Unresectable Re...	Clostridium but... Ipilimumab Nivolumab	18 Years -	City of Hope Medical Center
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Study	NCT05327686	Metastatic Rena... Stage III Renal... Stage IV Renal ... Unresectable Re...	Avelumab Axitinib Cabozantinib Ipilimumab Lenvatinib Nivolumab Pembrolizumab Stereotactic Ab...	18 Years -	NRG Oncology
Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies	NCT02419495	Advanced Malign... Clinical Stage ... Clinical Stage ... Fallopian Tube ... Metastatic Lung... Metastatic Mali... Metastatic Mela... Metastatic Rena... Ovarian Carcino... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Primary Periton... Stage III Lung ... Stage III Renal... Stage IIIA Lung... Stage IIIB Lung... Stage IIIC Lung... Stage IV Lung C... Stage IV Renal ... Stage IVA Lung ... Stage IVB Lung ... Triple-Negative... Unresectable Lu... Unresectable Me... Unresectable Re...	Capecitabine Carboplatin Cyclophosphamid... Doxorubicin Eribulin Fluorouracil Ipilimumab Irinotecan Hydr... Leucovorin Calc... Nivolumab Olaparib Oxaliplatin Paclitaxel Pembrolizumab Pemetrexed Selinexor Topotecan	18 Years -	M.D. Anderson Cancer Center

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: